Home/Pipeline/Fluticasone Furoate/Vilanterol (Relvar)

Fluticasone Furoate/Vilanterol (Relvar)

Asthma / COPD

ApprovedCommercial

Key Facts

Indication
Asthma / COPD
Phase
Approved
Status
Commercial
Company

About KYORIN Pharmaceutical

KYORIN Pharmaceutical is a mid-sized, revenue-generating Japanese pharmaceutical company with a diversified portfolio spanning prescription drugs, over-the-counter (OTC) products, and veterinary medicines. The company leverages its expertise in respiratory and urological diseases to maintain a stable revenue base from commercial products while investing in R&D for future growth. Its strategic focus includes lifecycle management of key brands and advancing its pipeline through internal research and selective partnerships.

View full company profile

Other Asthma / COPD Drugs

DrugCompanyPhase
APG273 (Zumilokibart + APG333)Apogee TherapeuticsPreclinical